Growth Metrics

Medpace Holdings (MEDP) Free Cash Flow (2016 - 2026)

Medpace Holdings filings provide 12 years of Free Cash Flow readings, the most recent being $145.0 million for Q1 2026.

  • On a quarterly basis, Free Cash Flow rose 25.15% to $145.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $711.0 million, a 31.44% increase, with the full-year FY2025 number at $681.9 million, up 19.15% from a year prior.
  • Free Cash Flow hit $145.0 million in Q1 2026 for Medpace Holdings, down from $188.1 million in the prior quarter.
  • In the past five years, Free Cash Flow ranged from a high of $235.5 million in Q3 2025 to a low of $37.0 million in Q1 2022.
  • Median Free Cash Flow over the past 5 years was $127.4 million (2022), compared with a mean of $126.3 million.
  • Biggest five-year swings in Free Cash Flow: dropped 27.18% in 2022 and later surged 108.58% in 2024.
  • Medpace Holdings' Free Cash Flow stood at $127.4 million in 2022, then grew by 14.88% to $146.4 million in 2023, then increased by 25.01% to $183.0 million in 2024, then increased by 2.78% to $188.1 million in 2025, then fell by 22.93% to $145.0 million in 2026.
  • The last three reported values for Free Cash Flow were $145.0 million (Q1 2026), $188.1 million (Q4 2025), and $235.5 million (Q3 2025) per Business Quant data.